Compounds > 14,15-epoxy-5,8,11-eicosatrienoic acid

14,15-epoxy-5,8,11-eicosatrienoic acid and anandamide

14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with anandamide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, YC; Wu, SN1
Feuerstein, TJ; Hollenberg, PF; Rae, JM; Sikora, MJ; Snider, NT; Sridar, C1
Hollenberg, PF; Snider, NT; Sridar, C1

Other Studies

3 other study(ies) available for 14,15-epoxy-5,8,11-eicosatrienoic acid and anandamide

ArticleYear
Block of erg current by linoleoylamide, a sleep-inducing agent, in pituitary GH3 cells.
    European journal of pharmacology, 2003, Jan-01, Volume: 458, Issue:1-2

    Topics: 8,11,14-Eicosatrienoic Acid; alpha-Linolenic Acid; Amides; Animals; Arachidonic Acid; Arachidonic Acids; Calcium; Calcium Channels, L-Type; Dose-Response Relationship, Drug; Endocannabinoids; Humans; Hydantoins; Imidazoles; Imidazolidines; Infant, Newborn; Linoleic Acids; Membrane Potentials; Neuroblastoma; Patch-Clamp Techniques; Piperazines; Piperidines; Pituitary Neoplasms; Polyunsaturated Alkamides; Potassium Channels; Pyridines; Tumor Cells, Cultured

2003
The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6.
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 327, Issue:2

    Topics: 8,11,14-Eicosatrienoic Acid; Arachidonic Acid; Arachidonic Acids; Brain; Cytochrome P-450 CYP2D6; Endocannabinoids; Epoxy Compounds; Humans; Hydroxylation; Microsomes; Mitochondria; Polyunsaturated Alkamides; Time Factors

2008
Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:5

    Topics: 8,11,14-Eicosatrienoic Acid; Amidohydrolases; Animals; Arachidonic Acids; Aryl Hydrocarbon Hydroxylases; Brain; Cannabinoid Receptor Modulators; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2D6; Endocannabinoids; Epoxide Hydrolases; Humans; Hydroxyeicosatetraenoic Acids; Hydroxylation; Male; Oxidation-Reduction; Oxidoreductases, N-Demethylating; Polymorphism, Genetic; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1

2011